Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria A V Willrich

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Clinical Chemistry and Laboratory Medicine|October 29, 2015
Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasiasMaria A V Willrich, Jerry A Katzmann
The Journal of Applied Laboratory Medicine|October 30, 2019
Evolution of Myeloma Testing in Clinical Chemistry with Mass SpectrometryDavid L Murray, Maria A V Willrich
Journal of Mass Spectrometry and Advances in the Clinical Lab|November 25, 2021
Ravulizumab: Characterization and quantitation of a new C5 inhibitor using isotype specific affinity purification and high-resolution mass spectrometryPaula M Ladwig, Maria A V Willrich
Clinical Chemistry|December 12, 2024
Applications of Mass Spectrometry Proteomic Methods to Immunoglobulins in the Clinical LaboratoryDavid L Murray, Maria A V Willrich
Journal of Immunological Methods|July 23, 2018
Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and managementMeera Sridharan, Ronald S Go, Maria A V Willrich
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 26, 2022
Clinical Utility and Potential Cost Savings of Pharmacologic Monitoring of Eculizumab for Complement-Mediated Thrombotic MicroangiopathyMeera Sridharan, Ronald S Go, Maria A V Willrich
Translational Research : the Journal of Laboratory and Clinical Medicine|October 12, 2014
Tumor necrosis factor inhibitors: clinical utility in autoimmune diseasesMaria A V Willrich, David L Murray, Melissa R Snyder
Journal of the American Society for Mass Spectrometry|December 23, 2016
Quantification of the IgG2/4 kappa Monoclonal Therapeutic Eculizumab from Serum Using Isotype Specific Affinity Purification and Microflow LC-ESI-Q-TOF Mass SpectrometryPaula M Ladwig, David R Barnidge, Maria A V Willrich
Clinical and Vaccine Immunology : CVI|March 10, 2017
Mass Spectrometry Approaches for Identification and Quantitation of Therapeutic Monoclonal Antibodies in the Clinical LaboratoryPaula M Ladwig, David R Barnidge, Maria A V Willrich
Clinical Biochemistry|May 9, 2017
Laboratory testing for monoclonal gammopathies: Focus on monoclonal gammopathy of undetermined significance and smoldering multiple myelomaMaria A V Willrich, David L Murray, Robert A Kyle
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Clinical Chemistry and Laboratory Medicine|October 29, 2015
Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasiasMaria A V Willrich, Jerry A Katzmann
The Journal of Applied Laboratory Medicine|October 30, 2019
Evolution of Myeloma Testing in Clinical Chemistry with Mass SpectrometryDavid L Murray, Maria A V Willrich
Journal of Mass Spectrometry and Advances in the Clinical Lab|November 25, 2021
Ravulizumab: Characterization and quantitation of a new C5 inhibitor using isotype specific affinity purification and high-resolution mass spectrometryPaula M Ladwig, Maria A V Willrich
Clinical Chemistry|December 12, 2024
Applications of Mass Spectrometry Proteomic Methods to Immunoglobulins in the Clinical LaboratoryDavid L Murray, Maria A V Willrich
Journal of Immunological Methods|July 23, 2018
Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and managementMeera Sridharan, Ronald S Go, Maria A V Willrich
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 26, 2022
Clinical Utility and Potential Cost Savings of Pharmacologic Monitoring of Eculizumab for Complement-Mediated Thrombotic MicroangiopathyMeera Sridharan, Ronald S Go, Maria A V Willrich
Translational Research : the Journal of Laboratory and Clinical Medicine|October 12, 2014
Tumor necrosis factor inhibitors: clinical utility in autoimmune diseasesMaria A V Willrich, David L Murray, Melissa R Snyder
Journal of the American Society for Mass Spectrometry|December 23, 2016
Quantification of the IgG2/4 kappa Monoclonal Therapeutic Eculizumab from Serum Using Isotype Specific Affinity Purification and Microflow LC-ESI-Q-TOF Mass SpectrometryPaula M Ladwig, David R Barnidge, Maria A V Willrich
Clinical and Vaccine Immunology : CVI|March 10, 2017
Mass Spectrometry Approaches for Identification and Quantitation of Therapeutic Monoclonal Antibodies in the Clinical LaboratoryPaula M Ladwig, David R Barnidge, Maria A V Willrich
Clinical Biochemistry|May 9, 2017
Laboratory testing for monoclonal gammopathies: Focus on monoclonal gammopathy of undetermined significance and smoldering multiple myelomaMaria A V Willrich, David L Murray, Robert A Kyle
Pageof 4